Interpreting continuous glucose monitoring (CGM) data can be complex due to the need to assess variability, hyperglycemia, and hypoglycemia simultaneously. The Glycemia Risk Index (GRI) provides a single, quantitative score that integrates these dimensions, enabling more streamlined evaluation of glycemic control.

A recent observational study published in the Journal of Diabetes Science and Technology evaluated how healthcare professionals perceive the clinical utility of the GRI. Twenty-eight Diabetes Care and Education Specialists (DCESs) and other clinicians participated in an educational session on GRI use and completed a structured survey. Most respondents preferred using the GRI alongside the Ambulatory Glucose Profile (AGP) when monitoring glycemic trends, and seventy-five percent expressed willingness to incorporate it into practice.

Participants rated the tool highly for advantages (mean score 4.57 of 5) and for usefulness in both primary care and specialty settings. Qualitative feedback emphasized that the GRI simplifies CGM interpretation, supports decision-making, and improves understanding of glucose dynamics, though respondents noted the need for broader dissemination and clinician training.

These findings suggest that the GRI could serve as a practical adjunct to standard CGM reports, offering a consistent framework to quantify glycemic risk and enhance the quality of diabetes care.